Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 18Recruiting 10Unknown 9Terminated 8Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 425Neoplasms 284Carcinoma, Non-Small-Cell Lung 274Colorectal Neoplasms 236Prostatic Neoplasms 173Lung Neoplasms 171Carcinoma, Hepatocellular 157Stomach Neoplasms 126Leukemia, Myeloid, Acute 120Pancreatic Neoplasms 118Multiple Myeloma 106Recurrence 100Uterine Cervical Neoplasms 97Squamous Cell Carcinoma of Head and Neck 89Neoplasm Metastasis 88Rectal Neoplasms 87Ovarian Neoplasms 81Triple Negative Breast Neoplasms 78Small Cell Lung Carcinoma 72Head and Neck Neoplasms 70Brain Neoplasms 70Glioblastoma 65Esophageal Neoplasms 65Endometrial Neoplasms 59Colonic Neoplasms 59Melanoma 56Hematologic Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Motor Activity 48Glioma 48

Interventions

edoxaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Venous Thrombosis × Clear all
NCT07372716 2026-02-06

ACE-HIGH

Ottawa Hospital Research Institute

Phase NA Not yet recruiting
700 enrolled

Atrial Fibrillation, Hemorrhage, Neoplasms, Thrombosis, Venous Thrombosis

NCT06149533 2023-11-29

Thrombosis

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Not yet recruiting
366 enrolled

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡